The Asia-Pacific DTC Laboratory Testing Market is projected to reach $1.58 billion by 2030, at a CAGR of 12.8% from 2023 to 2030. Direct-to-consumer or DTC tests are the ones that are self-ordered by consumers without the involvement of their healthcare providers. The sample that is collected from the consumer is processed at a laboratory, and the results are then sent directly to the consumer.
The growth of the Asia-Pacific DTC Laboratory testing market is driven by several factors, including the rising incidence of chronic diseases and sexually transmitted diseases, high disposable income, increased consumer awareness, increasing awareness about personal health management, benefits of DTC laboratory testing such as high convenience, affordability, and accessibility, increasing prevalence of chronic and infectious diseases, the increasing cost of healthcare, and the rising elderly population. Factors such as the growing adoption of telehealth, expansion in emerging economies, and the increasing penetration of pharmacogenomic testing in DTC laboratory testing are a few of the opportunities that would help grow the market in the future. Genetic data privacy concerns, misinterpretation of test results, and lack of professional medical counseling could be considered challenges for the Asia-Pacific DTC Laboratory testing market. However, sample integrity and interference issues, regulatory concerns, lack of reimbursement, and the limited test portfolio compared to conventional laboratory testing restrain the growth of the market.
Over the last few years, consumers have been actively participating in decisions affecting their health, enabling people to be informed of their health and lead healthy lifestyles. Clinical laboratory testing is an important part of healthcare. These tests can be ordered online or bought from pharmacies without any prescription, making them easy to access for consumers. The easy accessibility and convenience of ordering the tests online also attract customers.
Companies operating in this market are conducting marketing campaigns and advertisements to interest consumers and inform them about the benefits of DTC tests. This encourages customers to order these tests without needing to consult a physician. Consumers can get personalized information about their health, disease risk, and other traits and gain awareness of their genetic predisposition to illnesses using these DTC tests. Thus, ease of accessibility to DTC tests and effective marketing to consumers.
Click here to: Get Free Sample Pages of this Report
Increasing Population Coupled with Rising Chronic Diseases
The rising prevalence of chronic & infectious diseases is expected to drive the demand for DTC laboratory testing. Many DTC laboratory testing companies are offering tests for diagnosing infectious diseases and monitoring chronic diseases. China has the world’s largest population, with about 1.45 billion people as of 2023. The sheer large population of the country leads to high demand for various healthcare services, including DTC Laboratory services. The geriatric population is also estimated to reach 225 million in 2030 from 170 million in 2020. The elderly population is more prone to chronic and infectious diseases due to immune dysfunction, malnutrition, and aging-related physiological changes. The rising disease burden can directly affect a country’s social and economic status. Thus, it is necessary to adopt early diagnostic procedures to minimize the burden of these diseases. The large population, the rise in the geriatric population, and the rising prevalence of diseases have led to increased demand for DTC Laboratory testing. Thus, the advantages of DTC lab testing, such as discretion & confidentiality and the increased prevalence of sexually transmitted diseases, are expected to drive the demand for DTC lab testing.
The Genetic Testing Segment is Expected to Account for the Largest Share of the Market in 2023
Among all the applications, in 2023, the genetic testing segment is expected to account for the largest share of the market. DTC genetic tests are those that are provided directly to consumers without involving a healthcare provider. This testing generally offers a wide range of genetic tests that can be helpful to provide consumers with information about their ancestry, health risks, and traits. This segment is driven by factors such as increasing awareness regarding personal health management, high curiosity about self-ancestry, strong marketing strategies by the companies, rising prevalence of various genetic & chronic diseases, and high demand for personalized testing services.
The Blood Segment is Expected to Account for the Largest Share of the Market in 2023
Among sample types, in 2023, the blood segment is expected to account for the largest share of the market. The blood sample is collected from consumers to test conditions such as diabetes, routine clinical testing, thyroid function, and sexually transmitted disease testing, among others, in order to gain insight into how the organs are functioning. Blood samples are collected using a lancet or a needle that is present in the kit provided to carry out the test. This segment is driven by factors such as a large variety of available tests using blood samples, increasing prevalence of various chronic diseases, and increasing consumer awareness regarding the monitoring of chronic diseases.
Key Players
The key players profiled in the Asia-Pacific DTC Laboratory testing market report are Metropolis Healthcare Limited (India), SRL Limited (India), Hirotsu Bio Science (Japan), Mapmygenome India Limited (India), Genesis Healthcare Co. (Japan), Augmentum Diagnostics (India), Apollo Health and Lifestyle Limited (India), WeGene (China), GeseDNATechnology LLP (China), Laboratory Corporation of America Holdings (U.S.), LetsGetChecked, Inc. (U.S.), and 23andMe Holding Co. (U.S.).
The report includes a competitive landscape based on an extensive assessment of the market based on application, sample type, and geography. The report also provides insights into the geographic presence of major market players and their key growth strategies in the last three to four years.
Scope of the Report:
Asia-Pacific DTC Laboratory Testing Market, by Application
Asia-Pacific DTC Laboratory Testing Market, by Sample Type
Asia-Pacific DTC Laboratory Testing Market, by Country
Key questions answered in the report:
This market study covers the market sizes & forecasts of the direct-to-consumer (DTC) laboratory testing market in Asia-Pacific based on application, sample type, and geography. This market study also provides the value analysis of various segments and subsegments of the Asia-Pacific DTC laboratory testing market at country levels.
The Asia-Pacific dtc laboratory testing market is projected to reach $1.58 billion by 2030, at a CAGR of 12.8% during the forecast period.
The genetic testing segment is expected to account for the largest share of the market in 2023. Factors such as the rising appeal of DTC genetic testing to explore information regarding family health history and disease risk assessment testing, the launch of new DTC genetic tests for new applications, and increasing curiosity among people in developed countries regarding their ancestry and lineage.
The blood segment is expected to account for the largest share of the Asia-Pacific dtc laboratory testing market. The growth of this segment is attributed to the benefits of blood samples, such as the high reliability of results, the wide range of test options available, and the convenience of at-home blood collection service.
The growth of the Asia-Pacific dtc laboratory testing market is driven by several factors, including the increased awareness about personal health management, benefits of DTC laboratory testing, such as high convenience, affordability, & accessibility, increasing prevalence of chronic & infectious diseases, increasing cost of healthcare, increasing consumer awareness about ancestry/genealogy testing, and the rising elderly population.
Furthermore, the growing adoption of telehealth, expansion in emerging economies, and increasing penetration of pharmacogenomic testing in DTC laboratory testing serve as major opportunities for the existing market players and new entrants in the Asia-Pacific direct-to-consumer laboratory testing market.
The key players profiled in the Asia-Pacific dtc laboratory testing market report are Metropolis Healthcare Limited (India), SRL Limited (India), Hirotsu Bio Science (Japan), Mapmygenome India Limited (India), Genesis Healthcare Co. (Japan), Augmentum Diagnostics (India), Apollo Health and Lifestyle Limited (India), WeGene (China), GeseDNATechnology LLP (China), Laboratory Corporation of America Holdings (U.S.), LetsGetChecked, Inc. (U.S.), and 23andMe Holding Co. (U.S.).
Countries such as China and Japan are projected to offer significant growth opportunities for vendors operating in this market. This growth is mainly due to increased consumer awareness, high disposable income in the countries, rising incidence of chronic and sexually transmitted diseases, and favorable consumer behaviors in both countries.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumption for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increased Awareness About Personal Health Management
4.2.2. Benefits of DTC Laboratory Testing such as High Convenience, Affordability & Accessibility
4.2.3. Increasing Prevalence of Chronic & Infectious Diseases
4.2.4. Increasing Cost of Healthcare
4.2.5. Rising Elderly Population
4.3. Restraints
4.3.1. Sample Integrity and Interference Issues
4.3.2. Regulatory Concerns
4.3.3. Lack of Reimbursement
4.3.4. Limited Test Portfolio Compared to Conventional Laboratory Testing
4.4. Opportunities
4.4.1. Growing Adoption of Telehealth
4.4.2. Expansion in Emerging Economies
4.4.3. Increasing Penetration of Pharmacogenomic Testing in DTC Laboratory Testing
4.5. Challenges
4.5.1. Genetic Data Privacy Concerns
4.5.2. Misinterpretation of Test Results
4.5.3. Lack of Professional Medical Counselling
4.6. Industry & Technological Trends
4.7. Regulatory Scenario
4.8. Pricing Analysis
4.9. Adjacent/Related Markets
5. Asia-Pacific DTC Laboratory Testing Market Assessment—by Application
5.1. Overview
5.2. Genetic Testing
5.2.1. Ancestry/Genealogy
5.2.2. Disease Risk Assessment
5.2.2.1. Cancer
5.2.2.2. Cardiovascular Diseases
5.2.2.3. Neurological Diseases
5.2.2.4. Other Diseases
5.2.3. Carrier Status
5.2.4. Other Genetic Tests
5.3. Diabetes Testing
5.4. Routine Clinical Testing
5.5. Thyroid Function Testing
5.6. COVID-19 Testing
5.7. Sexually Transmitted Disease Testing
5.8. Other Applications
6. Asia-Pacific DTC Laboratory Testing Market Assessment—by Sample Type
6.1. Overview
6.2. Blood
6.3. Saliva
6.4. Urine
6.5. Other Samples
7. Asia-Pacific DTC Laboratory Testing Market Assessment—by Country
7.1. Overview
7.2. China
7.3. Japan
7.4. India
7.5. Australia
7.6. South Korea
7.7. Indonesia
7.8. Thailand
7.9. Malaysia
7.10. Singapore
7.11. Philippines
7.12. Vietnam
7.13. Rest of Asia-Pacific (RoAPAC)
8. Competition Analysis
8.1. Overview
8.2. Key Growth Strategies
8.3. Competitive Benchmarking
8.4. Competitive Dashboard
8.4.1. Industry Leaders
8.4.2. Market Differentiators
8.4.3. Vanguards
8.4.4. Emerging Companies
8.5. Market Share Analysis/Market Ranking (2022)
9. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
9.1. Metropolis Healthcare Limited (India)
9.2. SRL Limited (India)
9.3. Hirotsu Bio Science (Japan)
9.4. Mapmygenome India Limited (India)
9.5. Genesis Healthcare Co. (Japan)
9.6. Augmentum Diagnostics (India)
9.7. Apollo Health and Lifestyle Limited (India)
9.8. WeGene (China)
9.9. GeseDNATechnology LLP (China)
9.10. Laboratory Corporation of America Holdings (U.S.)
9.11. LetsGetChecked, Inc. (U.S.)
9.12. 23andMe Holding Co. (U.S.)
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
10. Appendix
10.1. Available Customization
10.2. Related Reports
List of Tables
Table 1 Asia-Pacific DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 2 Asia-Pacific Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 3 Asia-Pacific Direct-to-consumer Genetic Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 4 Asia-Pacific DTC Genetic Testing Market for Ancestry/Genealogy, by Country/Region, 2021–2030 (USD Million)
Table 5 Asia-Pacific DTC Genetic Testing Market for Diseases Risk Assessment, by Type, 2021–2030 (USD Million)
Table 6 Asia-Pacific DTC Genetic Testing Market for Diseases Risk Assessment, by Country/Region, 2021–2030 (USD Million)
Table 7 Asia-Pacific Disease Risk Assessment Testing Market for Cancer, by Country/Region, 2021–2030 (USD Million)
Table 8 Asia-Pacific Disease Risk Assessment Testing Market for Cardiovascular Diseases, by Country/Region, 2021–2030 (USD Million)
Table 9 Asia-Pacific Disease Risk Assessment Testing Market for Neurological Diseases, by Country/Region, 2021–2030 (USD Million)
Table 10 Asia-Pacific Disease Risk Assessment Testing Market for Other Diseases, by Country/Region, 2021–2030 (USD Million)
Table 11 Asia-Pacific DTC Genetic Testing Market for Carrier Status, by Country/Region, 2021–2030 (USD Million)
Table 12 Asia-Pacific DTC Genetic Testing Market for Other Genetic Tests, by Country/Region, 2021–2030 (USD Million)
Table 13 Asia-Pacific DTC Diabetes Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 14 Asia-Pacific DTC Routine Clinical Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 15 Asia-Pacific DTC Thyroid Function Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Asia-Pacific DTC Laboratory Testing Market for COVID-19 Testing, by Country/Region, 2021–2030 (USD Million)
Table 17 Asia-Pacific DTC Laboratory Testing Market for Sexually Transmitted Diseases, by Country/Region, 2021–2030 (USD Million)
Table 18 Asia-Pacific DTC Laboratory Testing Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 19 Asia-Pacific DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 20 Asia-Pacific DTC Laboratory Testing Market for Blood, by Country/Region, 2021–2030 (USD Million)
Table 21 Asia-Pacific DTC Laboratory Testing Market for Saliva, by Country/Region, 2021–2030 (USD Million)
Table 22 Asia-Pacific DTC Laboratory Testing Market for Urine, by Country/Region, 2021–2030 (USD Million)
Table 23 Asia-Pacific DTC Laboratory Testing Market for Other Samples, by Country/Region, 2021–2030 (USD Million)
Table 24 Asia-Pacific DTC Laboratory Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 25 China: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 26 China: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 27 China: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 28 China: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 29 Japan: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 30 Japan: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 31 Japan: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 32 Japan: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 33 India: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 34 India: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 35 India: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 36 India: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 37 Australia: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 38 Australia: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 39 Australia: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 40 Australia: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 41 South Korea: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 42 South Korea: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 43 South Korea: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 44 South Korea: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 45 Indonesia: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 46 Indonesia: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 47 Indonesia: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 48 Indonesia: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 49 Thailand: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 50 Thailand: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 51 Thailand: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 52 Thailand: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 53 Malaysia: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 54 Malaysia: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 55 Malaysia: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 56 Malaysia: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 57 Singapore: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 58 Singapore: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 59 Singapore: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 60 Singapore: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 61 Philippines: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 62 Philippines: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 63 Philippines: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 64 Philippines: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 65 Vietnam: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 66 Vietnam: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 67 Vietnam: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 68 Vietnam: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 69 Rest of Asia-Pacific: DTC Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 70 Rest of Asia-Pacific: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 71 Rest of Asia-Pacific: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 72 Rest of Asia-Pacific: DTC Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 73 Recent Developments, by Company, 2020–2023
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for the Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Asia-Pacific DTC Laboratory Testing Market Size, by Application, 2023 Vs. 2030 (USD Million)
Figure 8 Asia-Pacific DTC Laboratory Testing Market Size, by Sample Type, 2023 Vs. 2030 (USD Million)
Figure 9 DTC Laboratory Testing Market Size, by Geography
Figure 10 Asia-Pacific: DTC Laboratory Testing Market Snapshot
Figure 11 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 12 Competitive Dashboard: DTC Laboratory Testing Market
Figure 13 DTC Laboratory Testing Market: Vendor Benchmarking, by Application
Figure 14 DTC Laboratory Testing Market: Vendor Benchmarking, by Region
Figure 15 Asia-Pacific DTC Laboratory Testing Market Share Analysis, by Key Players, 2022 (%)
Figure 16 Metropolis Healthcare Ltd.: Financial Overview (2022)
Figure 17 Laboratory Corporation of America Holdings: Financial Overview (2022)
Figure 18 23andMe Holding Co.: Financial Overview (2022)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Nov-2023
Published Date: Nov-2023
Published Date: Oct-2023
Published Date: Sep-2023
Published Date: Aug-2023
